Journal
CNS NEUROSCIENCE & THERAPEUTICS
Volume 18, Issue 12, Pages 1003-1011Publisher
WILEY
DOI: 10.1111/cns.12019
Keywords
Biomarker; Hematoma enlargement; Intracerebral hemorrhage; MicroRNA
Categories
Funding
- Beijing Clinical Medicine (Neuroscience) interdisciplinary group project [PXM2010_014226_07_000094]
- National Natural Science Foundation of China [81000505]
- Beijing New Star Plan of Science and Technology [2007B047]
Ask authors/readers for more resources
Background and Purpose MicroRNAs have recently been shown to regulate the downstream bioprocesses of intracerebral hemorrhage. The aim of this study was to investigate whether miRNAs can be used as biomarkers to predict secondary hematoma enlargement (HE) in patients with ICH. Methods Consecutively, 79 ICH patients admitted within 6h of symptom onset and 30 healthy individuals were enrolled in this study. Whole-genome miRNA expression profiles were generated in 32 patients (HE/non-HE: 14/18). Representative differentially expressed miRNAs were measured in all cases (HE/non-HE: 30/49) and normal controls (n=30) by real-time PCR. Results Thirty miRNAs showed differential expressions in the plasma samples from patients with HE as compared with the non-HE controls. Compared to the hierarchical cluster analysis with all probes on microarray, all patients were separated into two main branches with only four exceptions by 30 differentially expressed miRNAs, improving the overall accuracy from 47.62 to 77.78% in the HE and 72.73 to 100% in the non-HE group. Further support vector machine (SVM) test can discriminate the two groups with 100% accuracy with 10 differentially expressed miRNAs. Conclusions We demonstrated that multiple miRNAs are differentially expressed in the plasma of ICH patients with or without HE and may serve as circulating biomarkers for predicting HE after ICH.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available